instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Helicobacter infection'. | Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.
BACKGROUND
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a r... | METHOTREXATE, METHYLPREDNISOLONE, TOFACITINIB | DrugsGivenReaction | CC BY | 33827581 | 19,158,055 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypogammaglobulinaemia'. | Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.
BACKGROUND
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a r... | ADALIMUMAB, METHOTREXATE, METHYLPREDNISOLONE, RITUXIMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33827581 | 19,574,198 | 2021-04-08 |
What was the administration route of drug 'TOFACITINIB'? | Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.
BACKGROUND
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a r... | Oral | DrugAdministrationRoute | CC BY | 33827581 | 19,574,198 | 2021-04-08 |
What was the outcome of reaction 'Bacteraemia'? | Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.
BACKGROUND
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a r... | Recovered | ReactionOutcome | CC BY | 33827581 | 19,574,198 | 2021-04-08 |
What was the outcome of reaction 'Helicobacter infection'? | Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.
BACKGROUND
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a r... | Recovered | ReactionOutcome | CC BY | 33827581 | 19,158,055 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angina unstable'. | Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease.
To assess the incremental long-term prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance (CMR) in patients without known coronary artery disease (CAD).
Bet... | DIPYRIDAMOLE, GADOTERATE MEGLUMINE | DrugsGivenReaction | CC BY | 33827603 | 19,317,479 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease.
To assess the incremental long-term prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance (CMR) in patients without known coronary artery disease (CAD).
Bet... | DIPYRIDAMOLE, GADOTERATE MEGLUMINE | DrugsGivenReaction | CC BY | 33827603 | 19,326,736 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ischaemia'. | Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease.
To assess the incremental long-term prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance (CMR) in patients without known coronary artery disease (CAD).
Bet... | DIPYRIDAMOLE, GADOTERATE MEGLUMINE | DrugsGivenReaction | CC BY | 33827603 | 19,326,744 | 2021-04-08 |
What was the administration route of drug 'DIPYRIDAMOLE'? | Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease.
To assess the incremental long-term prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance (CMR) in patients without known coronary artery disease (CAD).
Bet... | Other | DrugAdministrationRoute | CC BY | 33827603 | 19,326,736 | 2021-04-08 |
What was the dosage of drug 'GADOTERATE MEGLUMINE'? | Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease.
To assess the incremental long-term prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance (CMR) in patients without known coronary artery disease (CAD).
Bet... | A BOLUS OF GADOLINIUM?BASED CONTRAST AGENT (0.1 MMOL/?KG, DOTAREM) WAS INJECTED AT A RATE OF?5.0 ML/ | DrugDosageText | CC BY | 33827603 | 19,317,479 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
What was the dosage of drug 'BEVACIZUMAB'? | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | UNK, CYCLIC | DrugDosageText | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
What was the dosage of drug 'FLUOROURACIL'? | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | UNK, CYCLIC | DrugDosageText | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
What was the dosage of drug 'LEUCOVORIN'? | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | UNK, CYCLIC | DrugDosageText | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
What was the dosage of drug 'OXALIPLATIN'? | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | UNK, CYCLIC | DrugDosageText | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
What was the outcome of reaction 'Bradycardia'? | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | Recovered | ReactionOutcome | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
What was the outcome of reaction 'Interstitial lung disease'? | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | Recovered | ReactionOutcome | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
What was the outcome of reaction 'Pyrexia'? | Oxaliplatin-related interstitial pneumonia with high-grade fever and relative bradycardia as the presenting signs: a case report.
BACKGROUND
Although drug-induced interstitial pneumonia is a well-known adverse side-effect of cancer chemotherapy, the disease is difficult to detect in the early phase. We report a case of... | Recovered | ReactionOutcome | CC BY | 33827687 | 19,190,564 | 2021-04-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report.
Hyperkalemia is a life-threatening condition potentially leading to cardiac arrest. Here, we report a case of surprising severe hyperkalemia of 10.2 mmol/L in a diabetic patient with previously normal kidney function presenting witho... | POTASSIUM, RAMIPRIL, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33829044 | 19,136,207 | 2021 |
What was the dosage of drug 'POTASSIUM CHLORIDE'? | Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report.
Hyperkalemia is a life-threatening condition potentially leading to cardiac arrest. Here, we report a case of surprising severe hyperkalemia of 10.2 mmol/L in a diabetic patient with previously normal kidney function presenting witho... | 80.25 MMOL/DAY | DrugDosageText | CC BY-NC | 33829044 | 19,458,588 | 2021 |
What was the dosage of drug 'POTASSIUM CITRATE'? | Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report.
Hyperkalemia is a life-threatening condition potentially leading to cardiac arrest. Here, we report a case of surprising severe hyperkalemia of 10.2 mmol/L in a diabetic patient with previously normal kidney function presenting witho... | 80.25 MMOL/DAY | DrugDosageText | CC BY-NC | 33829044 | 19,491,109 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report.
Hyperkalemia is a life-threatening condition potentially leading to cardiac arrest. Here, we report a case of surprising severe hyperkalemia of 10.2 mmol/L in a diabetic patient with previously normal kidney function presenting witho... | Recovering | ReactionOutcome | CC BY-NC | 33829044 | 19,484,597 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aortic arteriosclerosis'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,410,594 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arterial disorder'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,416,113 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriosclerosis coronary artery'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,410,594 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriosclerosis'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,410,594 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Calcification metastatic'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,374,791 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,417,755 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,381,827 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, LANTHANUM CARBONATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,402,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mitral valve calcification'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,410,594 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Necrosis'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, LANTHANUM CARBONATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,402,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary calcification'. | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | CALCIUM ACETATE, PARICALCITOL, WARFARIN | DrugsGivenReaction | CC BY-NC | 33829045 | 19,410,594 | 2021 |
What was the administration route of drug 'PARICALCITOL'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33829045 | 19,410,594 | 2021 |
What was the dosage of drug 'CALCIUM ACETATE'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | UNKNOWN | DrugDosageText | CC BY-NC | 33829045 | 19,391,279 | 2021 |
What was the dosage of drug 'PARICALCITOL'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | UNKNOWN | DrugDosageText | CC BY-NC | 33829045 | 19,391,279 | 2021 |
What was the dosage of drug 'WARFARIN'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | UNKNOWN | DrugDosageText | CC BY-NC | 33829045 | 19,391,279 | 2021 |
What was the outcome of reaction 'Aortic arteriosclerosis'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Not recovered | ReactionOutcome | CC BY-NC | 33829045 | 19,410,594 | 2021 |
What was the outcome of reaction 'Aortic valve sclerosis'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Not recovered | ReactionOutcome | CC BY-NC | 33829045 | 19,410,594 | 2021 |
What was the outcome of reaction 'Arteriosclerosis coronary artery'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Not recovered | ReactionOutcome | CC BY-NC | 33829045 | 19,410,594 | 2021 |
What was the outcome of reaction 'Arteriosclerosis'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Not recovered | ReactionOutcome | CC BY-NC | 33829045 | 19,410,594 | 2021 |
What was the outcome of reaction 'Calcification metastatic'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Not recovered | ReactionOutcome | CC BY-NC | 33829045 | 19,374,791 | 2021 |
What was the outcome of reaction 'Death'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Fatal | ReactionOutcome | CC BY-NC | 33829045 | 19,417,755 | 2021 |
What was the outcome of reaction 'Disease progression'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Fatal | ReactionOutcome | CC BY-NC | 33829045 | 19,381,827 | 2021 |
What was the outcome of reaction 'Mitral valve calcification'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Not recovered | ReactionOutcome | CC BY-NC | 33829045 | 19,410,594 | 2021 |
What was the outcome of reaction 'Pulmonary calcification'? | Sequential Bone Scintigraphy and the Evolution of Warfarin-Mediated Calcific Uremic Arteriolopathy.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a complex syndrome of deranged mineral metabolism and vascular calcification leading to tissue ischemia that primarily occurs in end-stage renal disea... | Not recovered | ReactionOutcome | CC BY-NC | 33829045 | 19,410,594 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriosclerosis'. | Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.
Homozygous familial hypercholesterolemia (HoFH) is a rare, genetic condition in which mutations in key peptides involved in the low-density lipoprotein receptor (LDL-R) pathway result in markedly ele... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 33829367 | 19,160,045 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.
Homozygous familial hypercholesterolemia (HoFH) is a rare, genetic condition in which mutations in key peptides involved in the low-density lipoprotein receptor (LDL-R) pathway result in markedly ele... | EVOLOCUMAB | DrugsGivenReaction | CC BY-NC | 33829367 | 19,160,045 | 2021-05 |
What was the outcome of reaction 'Arteriosclerosis'? | Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.
Homozygous familial hypercholesterolemia (HoFH) is a rare, genetic condition in which mutations in key peptides involved in the low-density lipoprotein receptor (LDL-R) pathway result in markedly ele... | Fatal | ReactionOutcome | CC BY-NC | 33829367 | 19,160,045 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ulcerative'. | De novo ulcerative colitis after kidney transplantation treated with infliximab.
Diarrhea is a common complication in kidney transplant recipients. Common causes of diarrhea include infection, side effect from medication, rejection, and malignancy. A less common but important cause of diarrhea is de novo inflammatory b... | METHYLPREDNISOLONE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 33829404 | 19,158,054 | 2021-11 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | De novo ulcerative colitis after kidney transplantation treated with infliximab.
Diarrhea is a common complication in kidney transplant recipients. Common causes of diarrhea include infection, side effect from medication, rejection, and malignancy. A less common but important cause of diarrhea is de novo inflammatory b... | 2 mg (milligrams). | DrugDosage | CC BY | 33829404 | 19,158,054 | 2021-11 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | De novo ulcerative colitis after kidney transplantation treated with infliximab.
Diarrhea is a common complication in kidney transplant recipients. Common causes of diarrhea include infection, side effect from medication, rejection, and malignancy. A less common but important cause of diarrhea is de novo inflammatory b... | 750 mg (milligrams). | DrugDosage | CC BY | 33829404 | 19,158,054 | 2021-11 |
What was the dosage of drug 'TACROLIMUS'? | De novo ulcerative colitis after kidney transplantation treated with infliximab.
Diarrhea is a common complication in kidney transplant recipients. Common causes of diarrhea include infection, side effect from medication, rejection, and malignancy. A less common but important cause of diarrhea is de novo inflammatory b... | 4 mg (milligrams). | DrugDosage | CC BY | 33829404 | 19,158,054 | 2021-11 |
What was the outcome of reaction 'Colitis ulcerative'? | De novo ulcerative colitis after kidney transplantation treated with infliximab.
Diarrhea is a common complication in kidney transplant recipients. Common causes of diarrhea include infection, side effect from medication, rejection, and malignancy. A less common but important cause of diarrhea is de novo inflammatory b... | Recovered | ReactionOutcome | CC BY | 33829404 | 19,158,054 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain upper'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | BASILIXIMAB, COBICISTAT\DARUNAVIR ETHANOLATE, DOLUTEGRAVIR, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33830489 | 19,949,490 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'HIV infection'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperkalaemia'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunosuppressant drug level increased'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\DARUNAVIR ETHANOLATE, DOLUTEGRAVIR, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,158,484 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Insomnia'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Kaposi sarcoma inflammatory cytokine syndrome'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | BASILIXIMAB, EVEROLIMUS, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,388,846 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Polyomavirus-associated nephropathy'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Portal vein thrombosis'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | BASILIXIMAB, COBICISTAT\DARUNAVIR ETHANOLATE, DOLUTEGRAVIR, HEPATITIS B VIRUS VACCINE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RALTEGRAVIR, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,967,816 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | BASILIXIMAB, COBICISTAT\DARUNAVIR ETHANOLATE, DOLUTEGRAVIR, EVEROLIMUS, MYCOPHENOLIC ACID, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,163,634 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal tubular necrosis'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | BASILIXIMAB, COBICISTAT\DARUNAVIR ETHANOLATE, DOLUTEGRAVIR, EVEROLIMUS, MYCOPHENOLIC ACID, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,163,634 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transaminases increased'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | BASILIXIMAB, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,388,908 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transplant rejection'. | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | BASILIXIMAB, COBICISTAT\DARUNAVIR ETHANOLATE, DOLUTEGRAVIR, HEPATITIS B VIRUS VACCINE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RALTEGRAVIR, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33830489 | 19,967,816 | 2021-06 |
What was the administration route of drug 'COBICISTAT\DARUNAVIR ETHANOLATE'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Oral | DrugAdministrationRoute | CC BY-NC | 33830489 | 19,641,387 | 2021-06 |
What was the administration route of drug 'PREDNISONE'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Oral | DrugAdministrationRoute | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
What was the dosage of drug 'COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | 150/150/200/300 MG, QD | DrugDosageText | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 33830489 | 19,158,484 | 2021-06 |
What was the outcome of reaction 'Blood creatinine increased'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,163,634 | 2021-06 |
What was the outcome of reaction 'Drug interaction'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,163,634 | 2021-06 |
What was the outcome of reaction 'Drug level increased'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,641,387 | 2021-06 |
What was the outcome of reaction 'Immunosuppressant drug level increased'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,158,484 | 2021-06 |
What was the outcome of reaction 'Kaposi sarcoma inflammatory cytokine syndrome'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Not recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,388,846 | 2021-06 |
What was the outcome of reaction 'Kaposi^s sarcoma'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovering | ReactionOutcome | CC BY-NC | 33830489 | 19,158,484 | 2021-06 |
What was the outcome of reaction 'Nephropathy toxic'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,641,387 | 2021-06 |
What was the outcome of reaction 'Polyomavirus-associated nephropathy'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,183,386 | 2021-06 |
What was the outcome of reaction 'Portal vein thrombosis'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,967,816 | 2021-06 |
What was the outcome of reaction 'Proteinuria'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,163,634 | 2021-06 |
What was the outcome of reaction 'Renal impairment'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,163,635 | 2021-06 |
What was the outcome of reaction 'Renal tubular necrosis'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,163,634 | 2021-06 |
What was the outcome of reaction 'Transaminases increased'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,388,908 | 2021-06 |
What was the outcome of reaction 'Transplant rejection'? | Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT r... | Recovered | ReactionOutcome | CC BY-NC | 33830489 | 19,967,816 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | BISOPROLOL FUMARATE, CARBOPLATIN, CLOPIDOGREL BISULFATE, ENALAPRIL, IBRUTINIB, PACLITAXEL, PEMBROLIZUMAB, PREDNISONE, VALSARTAN, VENETOCLAX | DrugsGivenReaction | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | BISOPROLOL FUMARATE, CARBOPLATIN, CLOPIDOGREL BISULFATE, ENALAPRIL, IBRUTINIB, PACLITAXEL, PEMBROLIZUMAB, PREDNISONE, VALSARTAN, VENETOCLAX | DrugsGivenReaction | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia legionella'. | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | BISOPROLOL FUMARATE, CARBOPLATIN, CLOPIDOGREL BISULFATE, ENALAPRIL, IBRUTINIB, PACLITAXEL, PEMBROLIZUMAB, PREDNISONE, VALSARTAN, VENETOCLAX | DrugsGivenReaction | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
What was the administration route of drug 'BISOPROLOL FUMARATE'? | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | Oral | DrugAdministrationRoute | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
What was the administration route of drug 'CLOPIDOGREL BISULFATE'? | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | Oral | DrugAdministrationRoute | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
What was the administration route of drug 'ENALAPRIL'? | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | Oral | DrugAdministrationRoute | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
What was the administration route of drug 'IBRUTINIB'? | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | Oral | DrugAdministrationRoute | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
What was the administration route of drug 'PREDNISONE'? | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | Oral | DrugAdministrationRoute | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
What was the administration route of drug 'VALSARTAN'? | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | Oral | DrugAdministrationRoute | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
What was the administration route of drug 'VENETOCLAX'? | Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
BACKGROUND
Hypercalcemia is a common finding in patients with advanced-stage cancers. Paraneoplastic hypercalcemia is commonly associated with dismal prognoses, with survival rates of about 3 months. In... | Oral | DrugAdministrationRoute | CC BY | 33832072 | 19,176,253 | 2021-04-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.